IL-1RI deficiency ameliorates early experimental renal interstitial fibrosis.
BACKGROUND: IL-1beta has the potential to promote progressive renal disease by effects on macrophage recruitment and activation or by effects mediated through tubular cell transforming growth factor (TGF)-beta production, previously demonstrated in vitro. METHODS: The in vivo roles of endogenous IL...
Автори: | Jones, L, O'Sullivan, K, Semple, T, Kuligowski, M, Fukami, K, Ma, F, Nikolic-Paterson, D, Holdsworth, SR, Kitching, A |
---|---|
Формат: | Journal article |
Мова: | English |
Опубліковано: |
2009
|
Схожі ресурси
Схожі ресурси
-
Effect of interleukin 6 deficiency on renal interstitial fibrosis.
за авторством: Jun Yang, та інші
Опубліковано: (2012-01-01) -
FcεRI deficiency alleviates silica-induced pulmonary inflammation and fibrosis
за авторством: Yiling Chen, та інші
Опубліковано: (2022-10-01) -
FMS-like tyrosine kinase 3 ligand treatment does not ameliorate experimental rapidly progressive glomerulonephritis.
за авторством: Joanna R Ghali, та інші
Опубліковано: (2015-01-01) -
Cordycepin Ameliorates Renal Interstitial Fibrosis by Inhibiting Drp1-Mediated Mitochondrial Fission
за авторством: Sun Y, та інші
Опубліковано: (2025-02-01) -
Pseudomonas aeruginosa PA80 is a cystic fibrosis isolate deficient in RhlRI quorum sensing
за авторством: Syed A. K. Shifat Ahmed, та інші
Опубліковано: (2021-03-01)